Concepedia

Publication | Closed Access

A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors

15

Citations

16

References

2020

Year

References

YearCitations

Page 1